Article info
PDFPostScript
Letter
Better 5-year survival of fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: still too close to call
- Correspondence to Dr Basile Njei, Department of Medicine, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, Connecticut 06030-1845, USA; basilenjei{at}gmail.com
Citation
Better 5-year survival of fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: still too close to call
Publication history
- Received November 30, 2013
- Accepted December 7, 2013
- First published January 2, 2014.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions